NIMR explores safety of Azithromycin use on children
one year agoConsultant paediatrician and a research fellow at Nigerian Institute of Medical Research (NIMR), Dr. Abideen Salako (left); Director of Research at NIMR and a Consultant Obstetrician-Gynaecologist, Professor Oliver Ezechi; Director General of NIMR, Professor Oladapo Obafunwa; Director of Adimin, Mr. Bitrus Ezerendu and a Public Health Research fellow, Dr. Folahanmi Akinsolu during the NIMR monthly media chat held at the Institute's facility in Yaba, Lagos.
As part of efforts to reduce the country’s high child mortality rate, the Nigerian Institute of Medical Research (NIMR) has begun a nationwide study to determine the safety, effectiveness, and cost-efficiency of administering Azithromycin to children under the age of five.